BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34213743)

  • 41. Adult hypophosphatasia with compound heterozygous p.Phe327Leu missense and c.1559delT frameshift mutations in tissue-nonspecific alkaline phosphatase gene: a case report.
    Fukushima K; Kawai-Kowase K; Yonemoto Y; Fujiwara M; Sato H; Sato M; Kubota T; Ozono K; Tamura J
    J Med Case Rep; 2019 Apr; 13(1):101. PubMed ID: 31014398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular and clinical analysis of ALPL in a cohort of patients with suspicion of Hypophosphatasia.
    Tenorio J; Álvarez I; Riancho-Zarrabeitia L; Martos-Moreno GÁ; Mandrile G; de la Flor Crespo M; Sukchev M; Sherif M; Kramer I; Darnaude-Ortiz MT; Arias P; Gordo G; Dapía I; Martinez-Villanueva J; Gómez R; Iturzaeta JM; Otaify G; García-Unzueta M; Rubinacci A; Riancho JA; Aglan M; Temtamy S; Hamid MA; Argente J; Ruiz-Pérez VL; Heath KE; Lapunzina P
    Am J Med Genet A; 2017 Mar; 173(3):601-610. PubMed ID: 28127875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Follicle-stimulating hormone and estradiol are associated with bone mineral density and risk of fractures in men with type 2 diabetes mellitus.
    Jing Y; Wang X; Yu J; Wang X; Zhou Y; Tao B; Sun L; Liu J; Zhao H
    J Diabetes; 2020 Jun; 12(6):426-437. PubMed ID: 31778286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of osteoporosis and osteopenia diagnosed using quantitative CT in 296 consecutive lumbar fusion patients.
    Carlson BB; Salzmann SN; Shirahata T; Ortiz Miller C; Carrino JA; Yang J; Reisener MJ; Sama AA; Cammisa FP; Girardi FP; Hughes AP
    Neurosurg Focus; 2020 Aug; 49(2):E5. PubMed ID: 32738803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.
    Seminari E; Castagna A; Soldarini A; Galli L; Fusetti G; Dorigatti F; Hasson H; Danise A; Guffanti M; Lazzarin A; Rubinacci A
    HIV Med; 2005 May; 6(3):145-50. PubMed ID: 15876279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyridoxal 5'-phosphate and related metabolites in hypophosphatasia: Effects of enzyme replacement therapy.
    Akiyama T; Kubota T; Ozono K; Michigami T; Kobayashi D; Takeyari S; Sugiyama Y; Noda M; Harada D; Namba N; Suzuki A; Utoyama M; Kitanaka S; Uematsu M; Mitani Y; Matsunami K; Takishima S; Ogawa E; Kobayashi K
    Mol Genet Metab; 2018 Sep; 125(1-2):174-180. PubMed ID: 30049651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Membrane Transporter OAT7 (SLC22A9) Is Not a Susceptibility Factor for Osteoporosis in Europeans.
    Nies AT; Weiss S; Schaeffeler E; Hannemann A; Völker U; Wallaschofski H; Schwab M
    Front Endocrinol (Lausanne); 2020; 11():532. PubMed ID: 33013684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.
    Malluche HH; Davenport DL; Cantor T; Monier-Faugere MC
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1254-62. PubMed ID: 24948144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fractures and bone mineral density in adult women with 21-hydroxylase deficiency.
    Falhammar H; Filipsson H; Holmdahl G; Janson PO; Nordenskjöld A; Hagenfeldt K; Thorén M
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4643-9. PubMed ID: 17878254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of sclerostin and dkk1 in bone remodeling in type 2 diabetic patients.
    Wang N; Xue P; Wu X; Ma J; Wang Y; Li Y
    Endocr Res; 2018 Feb; 43(1):29-38. PubMed ID: 28972408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-1α gene variants influence bone mineral density and the risk of osteoporotic hip fractures in elderly Slovenian people.
    Zupan J; Pristovšek N; Mencej-Bedrač S; Komadina R; Preželj J; Marc J
    Clin Chem Lab Med; 2012 Feb; 50(8):1379-85. PubMed ID: 22868802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of metabolic bone disease in patients with endogenous hyperthyroidism: role of biological markers of bone turnover.
    Jódar Gimeno E; Muñoz-Torres M; Escobar-Jiménez F; Quesada Charneco M; Luna del Castillo JD; Oleà N
    Calcif Tissue Int; 1997 Nov; 61(5):370-6. PubMed ID: 9351877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteoporosis and metabolic syndrome according to socio-economic status, contribution of PTH, vitamin D and body weight: The Canarian Osteoporosis Poverty Study (COPS).
    Navarro Mdel C; Saavedra P; Jódar E; Gómez de Tejada MJ; Mirallave A; Sosa M
    Clin Endocrinol (Oxf); 2013 May; 78(5):681-6. PubMed ID: 23009563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between serum leptin levels and bone mineral density and bone metabolic markers in patients on hemodialysis.
    Ahmadi F; Salari S; Maziar S; Esfahanian F; Khazaeipour Z; Ranjbarnovin N
    Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):41-7. PubMed ID: 23354190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Is there a role for a random measurement of 24-hour urine calcium excretion and serum total alkaline phosphatase in the determination of fracture risk in osteoporotic postmenopausal women?].
    Barbu C; Roman A; Rotaru R; Fica S
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):291-4. PubMed ID: 17802933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiological, Clinical and Genetic Study of Hypophosphatasia in A Spanish Population: Identification of Two Novel Mutations in The Alpl Gene.
    García-Fontana C; Villa-Suárez JM; Andújar-Vera F; González-Salvatierra S; Martínez-Navajas G; Real PJ; Gómez Vida JM; de Haro T; García-Fontana B; Muñoz-Torres M
    Sci Rep; 2019 Jul; 9(1):9569. PubMed ID: 31267001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis.
    Rossini M; Zanotti R; Bonadonna P; Artuso A; Caruso B; Schena D; Vecchiato D; Bonifacio M; Viapiana O; Gatti D; Senna G; Riccio A; Passalacqua G; Pizzolo G; Adami S
    Bone; 2011 Oct; 49(4):880-5. PubMed ID: 21782049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone turnover and its relationship with bone mineral density in pre- and postmenopausal women with or without fractures.
    Minisola S; Pacitti MT; Ombricolo E; Costa G; Scarda A; Palombo E; Rosso R
    Maturitas; 1998 Jun; 29(3):265-70. PubMed ID: 9699199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort.
    Yoshimura N; Muraki S; Oka H; Kawaguchi H; Nakamura K; Akune T
    Mod Rheumatol; 2011 Dec; 21(6):608-20. PubMed ID: 21512822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The T869C TGF beta polymorphism is associated with fracture, bone mineral density, and calcaneal quantitative ultrasound in elderly women.
    Dick IM; Devine A; Li S; Dhaliwal SS; Prince RL
    Bone; 2003 Sep; 33(3):335-41. PubMed ID: 13678774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.